Abbott (ticker: ABT, exchange: New York Stock Exchange (.N))
News Release -
Abbott Announces New Products, Data and Positive Initiatives at 2007 AACC Annual Meeting
Highlights Include Introduction of More than 40 New Assays, 12 New Systems and
Expansion of 'Labs Are Vital(TM)' Initiative
SAN DIEGO, July 18 /PRNewswire-FirstCall/ -- Expanding on its growing
leadership position in the diagnostics market, Abbott today announced several
new product launches and initiatives at the American Association of Clinical
Chemistry (AACC) Annual Meeting, being held here from July 15-19.
"We are very pleased about the future of Abbott's diagnostic business,
including our core laboratory, molecular and point of care organizations,"
said Rick Gonzalez, president and chief operating officer, Abbott. "Abbott is
a market leader in the diagnostics segment and we have put the right
strategies in place to grow these businesses. Moving forward, I know that we
will approach these businesses with the same intensity and enthusiasm we bring
every day to serve our customers and grow our business."
Abbott Presence At AACC
Abbott has a significant presence at the four-day meeting. Abbott
Diagnostics is highlighting the strengthening of its assay offerings in the
metabolic, transplant, infectious disease and cardiac disease categories by
showcasing 40 assays and reagents that are new to the market or under late-
stage development for release. Abbott Diagnostics also is previewing 12 new
systems and solutions in its pipeline of analyzers, including the ARCHITECT(R)
c4000(R), ci4100(R), c16000(R), ci16200(R) and i1000SR(R). These products,
which will enable greater flexibility for clinical laboratories that have low-
to high-volume needs, are expected to be introduced throughout the second half
of 2007, 2008 and early 2009.
Abbott Molecular is showcasing its m2000(TM) automated instrument system
and the Abbott RealTime HIV-1 assay, designed to detect and precisely measure
levels of the human immunodeficiency virus (HIV) circulating in a patient's
blood (viral load), including the three major groups of HIV-1 as well as non-B
subtypes. The test is intended for use as a marker of disease prognosis and
an aid in assessing viral response to antiretroviral treatment.
Abbott Point of Care is featuring its industry leading i-STAT(R) system,
which provides trusted results and a comprehensive menu for point of care,
including: critical care chemistries, coagulation tests and lactate, as well
as recently introduced cardiac tests including Troponin, CK-MB and BNP.
Workshops Feature Presentations From Clinical Lab Research
and Industry Leaders
Abbott is hosting five workshops at the 2007 American Association for
Clinical Chemistry (AACC) Annual Meeting. The workshops will discuss
important topics and clinical outcomes affecting physician service and patient
care. The schedule of workshops includes sessions on immunochemistry systems,
cardiology, clinical chemistry, infectious disease and hematology.
For more information on Abbott Diagnostics' 2007 educational workshops,
Expansion of 'Labs Are Vital(TM)' Initiative
Currently, as many as 40,000 clinical lab science jobs are unfilled
because of labor shortages. "Labs Are Vital" is a multi-pronged, multi-year
education and awareness initiative designed to highlight the critical role
that laboratory professionals play in health care and to address the issues
that labs face today. Abbott is joined in this effort by the American Society
for Clinical Laboratory Science, the American Society for Clinical Pathology
and the Association of Public Health Laboratories.
Beginning this fall, "Labs Are Vital" will introduce a new online
recruiting program focused on college and high school students with an
interest in the life science professions.
AACC is an international scientific/medical society of clinical laboratory
professionals, physicians, research scientists and other individuals involved
with clinical chemistry and clinical laboratory science disciplines. Founded
in 1948, the society has 9,500 members and is headquartered in Washington,
D.C. AACC is subdivided geographically into 22 local sections.
The AACC Annual Meeting has become the "must attend" annual event for
anyone involved in performing, directing, interpreting or developing clinical
laboratory testing. Every year, the meeting attracts nearly 20,000
participants and nearly 700 exhibitors from more than 100 countries.
Abbott (NYSE: ABT) is a global, broad-based health care company devoted to
the discovery, development, manufacture and marketing of pharmaceuticals and
medical products, including nutritionals, devices and diagnostics. The
company employs 65,000 people and markets its products in more than 130
Abbott's news releases and other information are available on the
company's Web site at http://www.abbott.com.
CONTACT: Media, Ann Fahey-Widman, +1-847-772-0475, or Julie Herlocker,
+1-847-936-6116, or Financial, Tina Ventura, +1-847-935-9390, all of Abbott
Web site: http://www.abbott.com